Discussion about traditional Chinese medicine pharmacokinetics study based on first botanical drug approved by FDA / 中国中药杂志
China Journal of Chinese Materia Medica
; (24): 932-935, 2010.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-281683
Responsible library:
WPRO
ABSTRACT
Pharmacokinetics study is one of main components of pharmaceuticals development. Food and Drug Administration (FDA) approved Veregen as the first botanical drug in 2006. This article introduced FDA's requirement on pharmacokinetics study of botanical drug and pharmacokinetics studies of Veregen, summarized current requirement and status quo of pharmacokinetics study on traditional Chinese medicine (TCM) and natural medicine in China, and discussed about pharmacokinetics study strategy for TCM and natural medicine.
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
United States
/
United States Food and Drug Administration
/
Drugs, Chinese Herbal
/
Pharmacokinetics
/
Catechin
/
Chemistry
/
Chemistry, Pharmaceutical
/
Drug Approval
/
Medicine, Chinese Traditional
Type of study:
Diagnostic study
Country/Region as subject:
North America
Language:
Chinese
Journal:
China Journal of Chinese Materia Medica
Year:
2010
Document type:
Article